Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Evaluation of In-Flow Magnetoresistive Chip Cell-Counter as a Diagnostic Tool.

Giraud M, Delapierre FD, Wijkhuisen A, Bonville P, Thévenin M, Cannies G, Plaisance M, Paul E, Ezan E, Simon S, Fermon C, Féraudet-Tarisse C, Jasmin-Lebras G.

Biosensors (Basel). 2019 Aug 31;9(3). pii: E105. doi: 10.3390/bios9030105.

2.

Ultrasensitive bioanalysis: current status and future trends.

Simon S, Ezan E.

Bioanalysis. 2017 May;9(9):753-764. doi: 10.4155/bio-2017-0018. Epub 2017 May 10. Review.

PMID:
28488883
3.

Corrigendum: In vivo dynamics of active edema and lethal factors during anthrax.

Rougeaux C, Becher F, Ezan E, Tournier JN, Goossens PL.

Sci Rep. 2017 Feb 13;7:39579. doi: 10.1038/srep39579. No abstract available.

4.

In vivo dynamics of active edema and lethal factors during anthrax.

Rougeaux C, Becher F, Ezan E, Tournier JN, Goossens PL.

Sci Rep. 2016 Mar 21;6:23346. doi: 10.1038/srep23346. Erratum in: Sci Rep. 2017 Feb 13;7:39579.

5.

Mass spectrometry for the detection of bioterrorism agents: from environmental to clinical applications.

Duriez E, Armengaud J, Fenaille F, Ezan E.

J Mass Spectrom. 2016 Mar;51(3):183-99. doi: 10.1002/jms.3747. Review.

PMID:
26956386
6.

Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses.

Thévenot EA, Roux A, Xu Y, Ezan E, Junot C.

J Proteome Res. 2015 Aug 7;14(8):3322-35. doi: 10.1021/acs.jproteome.5b00354. Epub 2015 Jul 2.

PMID:
26088811
7.

Proteogenomic biomarkers for identification of Francisella species and subspecies by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Durighello E, Bellanger L, Ezan E, Armengaud J.

Anal Chem. 2014 Oct 7;86(19):9394-8. doi: 10.1021/ac501840g. Epub 2014 Sep 23.

PMID:
25215633
8.

Assessment of the metabolism of therapeutic proteins and antibodies.

Ezan E, Becher F, Fenaille F.

Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1079-91. doi: 10.1517/17425255.2014.925878. Epub 2014 Jun 4. Review.

PMID:
24897152
9.

Bacterial detection using unlabeled phage amplification and mass spectrometry through structural and nonstructural phage markers.

Martelet A, L'Hostis G, Tavares P, Brasilès S, Fenaille F, Rozand C, Theretz A, Gervasi G, Tabet JC, Ezan E, Junot C, Muller BH, Becher F.

J Proteome Res. 2014 Mar 7;13(3):1450-65. doi: 10.1021/pr400991t. Epub 2014 Feb 19.

PMID:
24517284
10.

Identification and validation of specific markers of Bacillus anthracis spores by proteomics and genomics approaches.

Chenau J, Fenaille F, Caro V, Haustant M, Diancourt L, Klee SR, Junot C, Ezan E, Goossens PL, Becher F.

Mol Cell Proteomics. 2014 Mar;13(3):716-32. doi: 10.1074/mcp.M113.032946. Epub 2013 Dec 29.

11.

Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers.

Azizi M, Blanchard A, Charbit B, Wuerzner G, Peyrard S, Ezan E, Funck-Brentano C, Ménard J.

Hypertension. 2013 Jun;61(6):1239-45. doi: 10.1161/HYPERTENSIONAHA.113.01196. Epub 2013 Apr 22.

PMID:
23608658
12.

Pharmacokinetic studies of protein drugs: past, present and future.

Ezan E.

Adv Drug Deliv Rev. 2013 Jul;65(8):1065-73. doi: 10.1016/j.addr.2013.03.007. Epub 2013 Mar 27. Review.

PMID:
23541379
13.

Mass spectrometry protocol for the absolute quantification of a monoclonal antibody in serum with immunopurification.

Becher F, Dubois M, Fenaille F, Ezan E.

Methods Mol Biol. 2013;988:345-52. doi: 10.1007/978-1-62703-327-5_22.

PMID:
23475731
14.

MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides.

Mesmin C, Renvoisé M, Becher F, Ezan E, Fenaille F.

Bioanalysis. 2012 Dec;4(23):2851-63. doi: 10.4155/bio.12.259. Review.

PMID:
23216125
15.

Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France.

Mazuet C, Ezan E, Volland H, Popoff MR, Becher F.

J Clin Microbiol. 2012 Dec;50(12):4091-4. doi: 10.1128/JCM.02392-12. Epub 2012 Sep 19.

16.

Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer.

Roux A, Xu Y, Heilier JF, Olivier MF, Ezan E, Tabet JC, Junot C.

Anal Chem. 2012 Aug 7;84(15):6429-37. doi: 10.1021/ac300829f. Epub 2012 Jul 17.

PMID:
22770225
17.

Mass spectrometric quantification of AcSDKP-NH2 in human plasma and urine and comparison with an immunoassay.

Mesmin C, Cholet S, Blanchard A, Chambon Y, Azizi M, Ezan E.

Rapid Commun Mass Spectrom. 2012 Jan 30;26(2):163-72. doi: 10.1002/rcm.5326.

PMID:
22173804
18.

Sensitive detection of Bacillus anthracis spores by immunocapture and liquid chromatography-tandem mass spectrometry.

Chenau J, Fenaille F, Ezan E, Morel N, Lamourette P, Goossens PL, Becher F.

Anal Chem. 2011 Nov 15;83(22):8675-82. doi: 10.1021/ac2020992. Epub 2011 Oct 18.

PMID:
21961787
19.

Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry.

Mesmin C, Fenaille F, Becher F, Tabet JC, Ezan E.

J Proteome Res. 2011 Nov 4;10(11):5222-31. doi: 10.1021/pr200725x. Epub 2011 Oct 13.

PMID:
21939284
20.

Investigating the plant response to cadmium exposure by proteomic and metabolomic approaches.

Villiers F, Ducruix C, Hugouvieux V, Jarno N, Ezan E, Garin J, Junot C, Bourguignon J.

Proteomics. 2011 May;11(9):1650-63. doi: 10.1002/pmic.201000645. Epub 2011 Apr 4. Review.

PMID:
21462346
21.

MS-based approaches for studying the pharmacokinetics of protein drugs.

Mesmin C, Fenaille F, Ezan E, Becher F.

Bioanalysis. 2011 Mar;3(5):477-80. doi: 10.4155/bio.11.21. No abstract available.

PMID:
21388259
22.

Bioanalysis of biotherapeutics at a crossroad.

Ezan E.

Bioanalysis. 2011 Mar;3(5):469-71. doi: 10.4155/bio.11.11. No abstract available.

23.

Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.

Ezan E, Becher F, Benech H, Fenaille F, Junot C, Mabondzo A, Pruvost A.

Bioanalysis. 2010 Apr;2(4):713-7. doi: 10.4155/bio.10.16. No abstract available.

24.

Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies.

Ezan E, Bitsch F.

Bioanalysis. 2009 Nov;1(8):1375-88. doi: 10.4155/bio.09.121. Review.

PMID:
21083085
25.

Evaluation of the LTQ-Orbitrap mass spectrometer for the analysis of polymerase chain reaction products.

Manduzio H, Ezan E, Fenaille F.

Rapid Commun Mass Spectrom. 2010 Dec 30;24(24):3501-9. doi: 10.1002/rcm.4800.

PMID:
21080500
26.

Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma.

Mesmin C, Dubois M, Becher F, Fenaille F, Ezan E.

Rapid Commun Mass Spectrom. 2010 Oct 15;24(19):2875-84. doi: 10.1002/rcm.4718.

PMID:
20857448
27.

Ultra-high performance liquid chromatography-mass spectrometry for the fast profiling of histone post-translational modifications.

Contrepois K, Ezan E, Mann C, Fenaille F.

J Proteome Res. 2010 Oct 1;9(10):5501-9. doi: 10.1021/pr100497a.

PMID:
20707390
28.

Fourier transform mass spectrometry for metabolome analysis.

Junot C, Madalinski G, Tabet JC, Ezan E.

Analyst. 2010 Sep;135(9):2203-19. doi: 10.1039/c0an00021c. Epub 2010 Jun 24. Review.

PMID:
20574587
29.

Evaluation of accurate mass and relative isotopic abundance measurements in the LTQ-orbitrap mass spectrometer for further metabolomics database building.

Xu Y, Heilier JF, Madalinski G, Genin E, Ezan E, Tabet JC, Junot C.

Anal Chem. 2010 Jul 1;82(13):5490-501. doi: 10.1021/ac100271j.

PMID:
20515063
30.

Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy.

Chabre H, Gouyon B, Huet A, Baron-Bodo V, Nony E, Hrabina M, Fenaille F, Lautrette A, Bonvalet M, Maillère B, Bordas-Le Floch V, Van Overtvelt L, Jain K, Ezan E, Batard T, Moingeon P.

Clin Exp Allergy. 2010 Mar;40(3):505-19. doi: 10.1111/j.1365-2222.2009.03380.x. Epub 2009 Nov 5. Erratum in: Clin Exp Allergy. 2010 Mar;40(3):517. Boran-Bodo, V [corrected to Baron-Bodo, V].

PMID:
19895591
31.

Comparison of approaches for purifying and desalting polymerase chain reaction products prior to electrospray ionization mass spectrometry.

Manduzio H, Martelet A, Ezan E, Fenaille F.

Anal Biochem. 2010 Mar 15;398(2):272-4. doi: 10.1016/j.ab.2009.10.026. Epub 2009 Oct 20.

PMID:
19850000
32.

Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens.

Fenaille F, Nony E, Chabre H, Lautrette A, Couret MN, Batard T, Moingeon P, Ezan E.

J Proteome Res. 2009 Aug;8(8):4014-27. doi: 10.1021/pr900359p.

PMID:
19572759
33.

Femtomolar detection of the anthrax edema factor in human and animal plasma.

Duriez E, Goossens PL, Becher F, Ezan E.

Anal Chem. 2009 Jul 15;81(14):5935-41. doi: 10.1021/ac900827s.

PMID:
19522516
34.

Bioanalysis of recombinant proteins and antibodies by mass spectrometry.

Ezan E, Dubois M, Becher F.

Analyst. 2009 May;134(5):825-34. doi: 10.1039/b819706g. Epub 2009 Mar 24. Review.

PMID:
19381370
35.

Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry.

Levi M, Wuerzner G, Ezan E, Pruvost A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 1;877(10):919-26. doi: 10.1016/j.jchromb.2009.02.030. Epub 2009 Feb 21.

PMID:
19264560
36.

Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends.

Werner E, Heilier JF, Ducruix C, Ezan E, Junot C, Tabet JC.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):143-63. doi: 10.1016/j.jchromb.2008.07.004. Epub 2008 Jul 12. Review.

PMID:
18672410
37.

Detection of ricin in complex samples by immunocapture and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Duriez E, Fenaille F, Tabet JC, Lamourette P, Hilaire D, Becher F, Ezan E.

J Proteome Res. 2008 Sep;7(9):4154-63. doi: 10.1021/pr8003437. Epub 2008 Jul 24.

PMID:
18651759
38.

Mass spectrometry-based metabolomics: accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution.

Werner E, Croixmarie V, Umbdenstock T, Ezan E, Chaminade P, Tabet JC, Junot C.

Anal Chem. 2008 Jul 1;80(13):4918-32. doi: 10.1021/ac800094p. Epub 2008 May 31.

PMID:
18512947
39.

Direct introduction of biological samples into a LTQ-Orbitrap hybrid mass spectrometer as a tool for fast metabolome analysis.

Madalinski G, Godat E, Alves S, Lesage D, Genin E, Levi P, Labarre J, Tabet JC, Ezan E, Junot C.

Anal Chem. 2008 May 1;80(9):3291-303. doi: 10.1021/ac7024915. Epub 2008 Mar 20.

PMID:
18351782
40.

Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum.

Dubois M, Fenaille F, Clement G, Lechmann M, Tabet JC, Ezan E, Becher F.

Anal Chem. 2008 Mar 1;80(5):1737-45. doi: 10.1021/ac7021234. Epub 2008 Jan 29.

PMID:
18225864
41.

A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A.

Volland H, Lamourette P, Nevers MC, Mazuet C, Ezan E, Neuburger LM, Popoff M, Créminon C.

J Immunol Methods. 2008 Jan 31;330(1-2):120-9. Epub 2007 Dec 17.

PMID:
18093612
42.

Detection of functional ricin by immunoaffinity and liquid chromatography-tandem mass spectrometry.

Becher F, Duriez E, Volland H, Tabet JC, Ezan E.

Anal Chem. 2007 Jan 15;79(2):659-65.

PMID:
17222034
43.

Immuno-mass spectrometry assay of EPI-HNE4, a recombinant protein inhibitor of human elastase.

Dubois M, Becher F, Herbet A, Ezan E.

Rapid Commun Mass Spectrom. 2007;21(3):352-8.

PMID:
17200977
44.

Validation of an ELISA for determination of antibodies induced in monkeys against Epi-hNE4, a recombinant protein inhibitor of human neutrophil elastase.

Dubois M, Delaunay V, Delestre L, Ezan E.

J Pharm Biomed Anal. 2007 Mar 12;43(4):1423-9. Epub 2006 Nov 21.

PMID:
17118611
45.

New insights into the regulation of phytochelatin biosynthesis in A. thaliana cells from metabolite profiling analyses.

Ducruix C, Junot C, Fiévet JB, Villiers F, Ezan E, Bourguignon J.

Biochimie. 2006 Nov;88(11):1733-42. Epub 2006 Sep 7.

PMID:
16996193
46.
47.

The early responses of Arabidopsis thaliana cells to cadmium exposure explored by protein and metabolite profiling analyses.

Sarry JE, Kuhn L, Ducruix C, Lafaye A, Junot C, Hugouvieux V, Jourdain A, Bastien O, Fievet JB, Vailhen D, Amekraz B, Moulin C, Ezan E, Garin J, Bourguignon J.

Proteomics. 2006 Apr;6(7):2180-98.

PMID:
16502469
48.

Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.

Josserand V, Pélerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, Ducongé F, Boisgard R, Beuvon F, Chassoux F, Daumas-Duport C, Ezan E, Dollé F, Mabondzo A, Tavitian B.

J Pharmacol Exp Ther. 2006 Jan;316(1):79-86. Epub 2005 Oct 6.

PMID:
16210395
49.

Combined proteome and metabolite-profiling analyses reveal surprising insights into yeast sulfur metabolism.

Lafaye A, Junot C, Pereira Y, Lagniel G, Tabet JC, Ezan E, Labarre J.

J Biol Chem. 2005 Jul 1;280(26):24723-30. Epub 2005 Apr 26.

50.

Liquid chromatography-mass spectrometry and 15N metabolic labeling for quantitative metabolic profiling.

Lafaye A, Labarre J, Tabet JC, Ezan E, Junot C.

Anal Chem. 2005 Apr 1;77(7):2026-33.

PMID:
15801734

Supplemental Content

Support Center